- « Previous
- Clinical Pharmacology
- Next »
Rezulin
Clinical Pharmacology
Clinical Pharmacology
Rezulin
226
231
220
-31
-38
-56
-54"
-61**
-79**
9.5
9.7
9.5
-0.7
-0.9
-1.8
-1.6"
-1.8**
-2.7*
28.2
24.9
26.4
-3.8
-5.9
-6.1
-2.4
-4.4'
-4.6"
** p <0. 0001 compared to continuation of glyburide monotherapy.
TABLE 3.
| Combination Therapy With Glyburide: Percent of Patients Achieving Glycemic Control at End of Study (1 yr) | ||||
| Rezulin (mg) | 0 | 200 | 400 | 600 |
| Glyburide (mg) | 12 | 12 | 12 | 12 |
| HbA, 1C % | ||||
| <7% | 1 | 22 | 21 | 41 |
| <8% | 10 | Brand Name: Rezulin
Generic Name: Troglitazone (removed from the US market 3/21/00)
WebMD DailyGet breaking medical news. | ||
